SLC2A3 and cancer: However, in cancer, P53 not only loses its function but it gains an oncogenic function (mutp53) which can inhibit AMPK and upregulate glucose transporters, GLUT1, GLUT3, and GLUT4, to proliferate under energy deficient conditions (93, 94).